Overview
Gastric intestinal metaplasia (GIM) is a premalignant condition characterized by the transformation of normal gastric mucosa into intestinal-type epithelium, increasing the risk of progression to gastric cancer 1.Diagnosis
Endoscopic Identification: Typically identified incidentally during upper endoscopy 1.
Biopsy Confirmation: Histological examination of biopsy samples is essential for diagnosis 1.
Grading Systems: Utilizes the Vienna classification system to grade severity (Intestinal Metaplasia types 1-3) 1.Management
Shared Decision-Making: Surveillance recommendations based on patient-specific risk factors, including age, family history, and extent of metaplasia 1.
Surveillance Frequency: Variable based on individual risk stratification; guidelines emphasize individualized approach 1.Special Populations
No Specific Guidance Provided: Abstracts do not provide detailed management strategies for pregnancy, pediatrics, elderly, or specific comorbidities 1.Key Recommendations
Implement Shared Decision-Making: Engage in shared decision-making with patients regarding GIM surveillance, considering individual risk factors 1 (Evidence: Moderate).
Increase Patient Communication: Communicate GIM findings and surveillance options more frequently to patients post-2020 guidelines 1 (Evidence: Moderate).
Tailored Surveillance Plans: Develop surveillance plans tailored to patient-specific risk factors rather than adopting a one-size-fits-all approach 1 (Evidence: Expert opinion).References
1 Rouphael C, Elkin B, El Dahdah J, Moufawad M, Yang Q, Bena J et al.. Practice Trends among US Gastroenterologists following the 2020 American Gastroenterological Association Guidelines on Gastric Intestinal Metaplasia: Data from a Tertiary Care Center. Journal of clinical gastroenterology 2025. link